- Home
- VCIC vs YMAB Comparison
VCIC vs YMAB Comparison
Compare VCIC & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIC
- YMAB
- Stock Information
- Founded
- VCIC 2024
- YMAB 2015
- Country
- VCIC United States
- YMAB United States
- Employees
- VCIC N/A
- YMAB N/A
- Industry
- VCIC
- YMAB Biotechnology: Pharmaceutical Preparations
- Sector
- VCIC
- YMAB Health Care
- Exchange
- VCIC NYSE
- YMAB Nasdaq
- Market Cap
- VCIC 295.4M
- YMAB 270.5M
- IPO Year
- VCIC 2024
- YMAB 2018
- Fundamental
- Price
- VCIC $10.10
- YMAB $5.72
- Analyst Decision
- VCIC
- YMAB Strong Buy
- Analyst Count
- VCIC 0
- YMAB 10
- Target Price
- VCIC N/A
- YMAB $21.10
- AVG Volume (30 Days)
- VCIC 9.8K
- YMAB 542.6K
- Earning Date
- VCIC 01-01-0001
- YMAB 03-04-2025
- Dividend Yield
- VCIC N/A
- YMAB N/A
- EPS Growth
- VCIC N/A
- YMAB N/A
- EPS
- VCIC N/A
- YMAB N/A
- Revenue
- VCIC N/A
- YMAB $84,553,000.00
- Revenue This Year
- VCIC N/A
- YMAB $6.41
- Revenue Next Year
- VCIC N/A
- YMAB $18.15
- P/E Ratio
- VCIC N/A
- YMAB N/A
- Revenue Growth
- VCIC N/A
- YMAB N/A
- 52 Week Low
- VCIC $9.96
- YMAB $5.60
- 52 Week High
- VCIC $10.99
- YMAB $20.90
- Technical
- Relative Strength Index (RSI)
- VCIC N/A
- YMAB 35.08
- Support Level
- VCIC N/A
- YMAB $5.60
- Resistance Level
- VCIC N/A
- YMAB $6.57
- Average True Range (ATR)
- VCIC 0.00
- YMAB 0.38
- MACD
- VCIC 0.00
- YMAB 0.10
- Stochastic Oscillator
- VCIC 0.00
- YMAB 11.43
About VCIC VINE HILL CAP INVT CORP
Vine Hill Capital Investment Corp is a blank check company.
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.